Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Vaccine formulations comprising quillaja desacylsaponins and beta amyloid peptides or tau protein to induce a Th2 immune response

Vaccine formulations comprising quillaja desacylsaponins and beta amyloid peptides or tau protein to induce a Th2 immune response

US Patent 10195257 · Granted Feb 5, 2019

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Imine-forming polysaccharide adjuvants and immunostimulants2007
Use of imine-forming polysaccharides as adjuvants and immunostimulants2005
Modified polysaccharide adjuvant-protein antigen conjugates, the preparation the2003
Chemically modified saponins and the use thereof as adjuvants2001
Immunostimulating and vaccine compositions employing saponin analog adjuvants an2000
Triterpene saponin analogs having adjuvant and immunostimulatory activity1999
Drug delivery enhancement via modified saponins1997
Saponin-antigen conjugates and the use thereof1996
Modified saponins isolated from Quillaja saponaria1995
Vaccine comprising recombinant feline leukemia antigen and saponin adjuvant1994
Methods for enhancing drug delivery with modified saponins1993
Monoclonal antibodies specific for Toxin B of Clostridium difficile1993